Benjamin G. Keselowsky is a Professor in the J. Crayton Pruitt Family Department of Biomedical Engineering at the University of Florida's Herbert Wertheim College of Engineering. His research focuses on engineering biomaterial-immune cell interactions and controlled release systems for immunotherapies, with applications in implanted devices, vaccines, and tissue engineering. He holds a B.S. in Chemical Engineering (University of South Florida, 1998) and a Ph.D. in Bioengineering (Georgia Institute of Technology, 2004). Key honors include AIMBE Fellowship (2018), UF Preeminence Term Professorship (2017-2020), and UF Research Foundation Professorship (2015-2018). His work bridges biomaterials science and immunology, emphasizing translational strategies for immune modulation. Recent efforts include developing bioresorbable alloys, enzyme-delivery systems, and antigen-specific microparticle therapies. Education: B.S., Chemical Engineering, University of South Florida (1998); Ph.D., Bioengineering, Georgia Tech (2004) Research Themes: Biomaterial-Immune System Interactions Controlled Release of Immune Modulators Tissue Engineering and Regenerative Medicine Awards: AIMBE Fellow (2018) UF Preeminence Term Professor (2017-2020) UF Research Foundation Professor (2015-2018) His lab's innovations include microparticle systems for treating autoimmune diseases and enzymatic gels for localized therapy. Collaborations span biomaterials design, immunotherapy development, and clinical translation.













